article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027.

article thumbnail

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

It’s hard to divvy all that because we work with medical affairs and medical science liaisons. By 2027, they are projected to be about $10 billion. In our direct team, there are thirteen FCE or Field Clinical Engineers. We have two managers. It’s such a broad team. Everybody’s buying now.

article thumbnail

Innovations in Cancer Research & Treatment: Leveraging Modern Technologies to Overcome Global Challenges

PM360

billion by 2027, growing at a CAGR of 25.8%. The conversation revealed a vision for a future where advanced technologies and preventive care work together to improve health outcomes, pushing the boundaries of medical science. Hait’s insights on advancing innovation and collaboration in the fight against cancer.